369 related articles for article (PubMed ID: 32331305)
1. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.
Carvalho ACA; Souza GA; Marqui SV; Guiguer ÉL; Araújo AC; Rubira CJ; Goulart RA; Flato UAP; Bueno PCDS; Buchaim RL; Barbalho SM
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331305
[TBL] [Abstract][Full Text] [Related]
2. An overview of cannabis based treatment in Crohn's disease.
Naftali T
Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):253-257. PubMed ID: 32149543
[No Abstract] [Full Text] [Related]
3. Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Inflamm Bowel Dis; 2020 Mar; 26(4):502-509. PubMed ID: 31613959
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Hasenoehrl C; Storr M; Schicho R
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
[TBL] [Abstract][Full Text] [Related]
5. Cannabis use amongst patients with inflammatory bowel disease.
Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
[TBL] [Abstract][Full Text] [Related]
6. Cannabis for inflammatory bowel disease.
Naftali T; Mechulam R; Lev LB; Konikoff FM
Dig Dis; 2014; 32(4):468-74. PubMed ID: 24969296
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians.
Buckley MC; Kumar A; Swaminath A
Adv Ther; 2021 Jul; 38(7):4152-4161. PubMed ID: 34110607
[TBL] [Abstract][Full Text] [Related]
8. Emerging immunological targets in inflammatory bowel disease.
Monteleone G; Pallone F; MacDonald TT
Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
[TBL] [Abstract][Full Text] [Related]
9. Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.
Naftali T; Bar-Lev Schleider L; Dotan I; Lansky EP; Sklerovsky Benjaminov F; Konikoff FM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1276-1280.e1. PubMed ID: 23648372
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Use of Curcumin on Ulcerative Colitis and Crohn's Disease: A Systematic Review.
Goulart RA; Barbalho SM; Lima VM; Souza GA; Matias JN; Araújo AC; Rubira CJ; Buchaim RL; Buchaim DV; Carvalho ACA; Guiguer ÉL
J Med Food; 2021 Jul; 24(7):675-685. PubMed ID: 33155879
[TBL] [Abstract][Full Text] [Related]
11. Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease.
Rivera Rodríguez R; Johnson JJ
Pharmacol Ther; 2023 Aug; 248():108456. PubMed ID: 37247693
[TBL] [Abstract][Full Text] [Related]
12. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
[TBL] [Abstract][Full Text] [Related]
13. Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.
Neubauer K; Kempinski R; Matusiewicz M; Bednarz-Misa I; Krzystek-Korpacka M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30986917
[No Abstract] [Full Text] [Related]
14. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
15. [Polyphenols in the treatment of inflammatory bowel diseases].
Chojnacka K; Laskowska J
Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R
Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286
[TBL] [Abstract][Full Text] [Related]
17. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.
Stefanelli T; Malesci A; Repici A; Vetrano S; Danese S
Curr Drug Targets; 2008 May; 9(5):413-8. PubMed ID: 18473770
[TBL] [Abstract][Full Text] [Related]
18. The role of integrin antagonists in the treatment of inflammatory bowel disease.
Beniwal-Patel P; Saha S
Expert Opin Biol Ther; 2014 Dec; 14(12):1815-23. PubMed ID: 25288228
[TBL] [Abstract][Full Text] [Related]
19. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
20. Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
Hansen TM; Sabourin BC; Oketola B; Bernstein CN; Singh H; Targownik LE
Inflamm Bowel Dis; 2020 Aug; 26(9):1401-1406. PubMed ID: 31725152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]